Synthetic BiologyMolecular TherapyPeer-reviewed
A SARS-CoV-2 targeted siRNA-nanoparticle therapy for COVID-19
Adi Idris, Alicia M. Davis, Aroon Supramaniam…·Kevin V. Morris
This paper develops an siRNA-nanoparticle therapy targeting SARS-CoV-2 that reduces viral load and improves survival in mice.
165 citationstop 1%